Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist - PubMed (original) (raw)
Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist
J Leprince et al. Eur J Biochem. 2001 Dec.
Free article
Abstract
The octadecaneuropeptide (ODN; QATVGDVNTDRPGLLDLK) and its C-terminal octapeptide (OP; RPGLLDLK), which exert anxiogenic activity, have been previously shown to increase intracellular calcium concentration ([Ca2+]i) in cultured rat astrocytes through activation of a metabotropic receptor positively coupled to phospholipase C. It has also been found that the [d-Leu5]OP analog possesses a weak antagonistic activity. The aim of the present study was to synthesize and characterize cyclic analogs of OP and [d-Leu5]OP. On-resin homodetic backbone cyclization of OP yielded an analog, cyclo1-8 OP, which was three times more potent and 1.4-times more efficacious than OP to increase [Ca2+]i in cultured rat astrocytes. Cyclo1-8 OP also mimicked the effect of both OP and ODN on polyphosphoinositide turnover. Conversely, the cyclo1-8 [d-Leu5]OP analog was totally devoid of agonistic activity but suppressed the effect of OP and ODN on [Ca2+]i and phosphoinositide metabolism in astrocytes. The structure of these cyclic analogs has been determined by two-dimensional 1H-NMR and molecular dynamics. Cyclo1-8 OP exhibited a single conformation characterized by a gamma turn comprising residues Pro2-Leu4 and a type III beta turn encompassing residues Leu5-Lys8. Cyclo1-8 [d-Leu5]OP was present as two equimolar conformers resulting from cis/trans isomerization of the Arg-Pro peptide bond. These pharmacological and structural data should prove useful for the rational design of non peptidic ODN analogs.
Similar articles
- Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes.
Leprince J, Gandolfo P, Thoumas JL, Patte C, Fauchère JL, Vaudry H, Tonon MC. Leprince J, et al. J Med Chem. 1998 Nov 5;41(23):4433-8. doi: 10.1021/jm980275d. J Med Chem. 1998. PMID: 9804683 - Structure-activity relationships of a series of analogs of the endozepine octadecaneuropeptide (ODN(11)(-)(18)) on neurosteroid biosynthesis by hypothalamic explants.
Rego JL, Leprince J, Luu-The V, Pelletier G, Tonon MC, Vaudry H. Rego JL, et al. J Med Chem. 2007 Jun 28;50(13):3070-6. doi: 10.1021/jm0610548. Epub 2007 Jun 6. J Med Chem. 2007. PMID: 17550241 - Pharmacological characterization of the receptor mediating the anorexigenic action of the octadecaneuropeptide: evidence for an endozepinergic tone regulating food intake.
do Rego JC, Orta MH, Leprince J, Tonon MC, Vaudry H, Costentin J. do Rego JC, et al. Neuropsychopharmacology. 2007 Jul;32(7):1641-8. doi: 10.1038/sj.npp.1301280. Epub 2006 Dec 6. Neuropsychopharmacology. 2007. PMID: 17151595 - Octadecaneuropeptide ODN prevents hydrogen peroxide-induced oxidative damage of biomolecules in cultured rat astrocytes.
Hamdi Y, Kaddour H, Vaudry D, Leprince J, Zarrouk A, Hammami M, Vaudry H, Tonon MC, Amri M, Masmoudi-Kouki O. Hamdi Y, et al. Peptides. 2015 Sep;71:56-65. doi: 10.1016/j.peptides.2015.06.010. Epub 2015 Jul 2. Peptides. 2015. PMID: 26143507 Review. - Neuroprotection with the Endozepine Octadecaneuropeptide, ODN.
Masmoudi-Kouki O, Hamdi Y, Ghouili I, Bahdoudi S, Kaddour H, Leprince J, Castel H, Vaudry H, Amri M, Vaudry D, Tonon MC. Masmoudi-Kouki O, et al. Curr Pharm Des. 2018;24(33):3918-3925. doi: 10.2174/1381612824666181112111746. Curr Pharm Des. 2018. PMID: 30417780 Review.
Cited by
- Sex-dependent endozepinergic regulation of ventromedial hypothalamic nucleus glucose counter-regulatory neuron aromatase protein expression in the adult rat.
Mahmood ASMH, Roy SC, Leprince J, Briski KP. Mahmood ASMH, et al. J Chem Neuroanat. 2023 Oct;132:102323. doi: 10.1016/j.jchemneu.2023.102323. Epub 2023 Aug 3. J Chem Neuroanat. 2023. PMID: 37543285 Free PMC article. - Glycogen phosphorylase isoenzyme GPbb versus GPmm regulation of ventromedial hypothalamic nucleus glucoregulatory neurotransmitter and counter-regulatory hormone profiles during hypoglycemia: Role of L-lactate and octadecaneuropeptide.
Uddin MM, Ali MH, Mahmood ASMH, Bheemanapally K, Leprince J, Briski KP. Uddin MM, et al. Mol Cell Neurosci. 2023 Sep;126:103863. doi: 10.1016/j.mcn.2023.103863. Epub 2023 May 31. Mol Cell Neurosci. 2023. PMID: 37268282 Free PMC article. - Structural and Functional Characterization of Orcokinin B-like Neuropeptides in the Cuttlefish (Sepia officinalis).
Endress M, Zatylny-Gaudin C, Leprince J, Lefranc B, Corre E, Le Corguillé G, Bernay B, Leduc A, Rangama J, Mouret L, Lafont AG, Bondon A, Henry J. Endress M, et al. Mar Drugs. 2022 Aug 4;20(8):505. doi: 10.3390/md20080505. Mar Drugs. 2022. PMID: 36005508 Free PMC article. - Astrocyte Gliotransmission in the Regulation of Systemic Metabolism.
Murat CB, García-Cáceres C. Murat CB, et al. Metabolites. 2021 Oct 26;11(11):732. doi: 10.3390/metabo11110732. Metabolites. 2021. PMID: 34822390 Free PMC article. Review. - The Gliopeptide ODN, a Ligand for the Benzodiazepine Site of GABAA Receptors, Boosts Functional Recovery after Stroke.
Lamtahri R, Hazime M, Gowing EK, Nagaraja RY, Maucotel J, Alasoadura M, Quilichini PP, Lehongre K, Lefranc B, Gach-Janczak K, Marcher AB, Mandrup S, Vaudry D, Clarkson AN, Leprince J, Chuquet J. Lamtahri R, et al. J Neurosci. 2021 Aug 18;41(33):7148-7159. doi: 10.1523/JNEUROSCI.2255-20.2021. Epub 2021 Jul 1. J Neurosci. 2021. PMID: 34210784 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous